Legal Representation
Attorney
Krista Weber Powell
USPTO Deadlines
Next Deadline
978 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2022-04-05)
Due Date
April 05, 2028
Grace Period Ends
October 05, 2028
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
33 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Sep 20, 2022 | FINO | P | FINAL DECISION TRANSACTION PROCESSED BY IB | Loading... |
| Aug 25, 2022 | FIMP | P | FINAL DISPOSITION PROCESSED | Loading... |
| Aug 25, 2022 | FICS | P | FINAL DISPOSITION NOTICE SENT TO IB | Loading... |
| Jul 5, 2022 | FICR | P | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | Loading... |
| Apr 10, 2022 | OPNX | P | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | Loading... |
| Apr 5, 2022 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Mar 23, 2022 | OPNR | P | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | Loading... |
| Mar 23, 2022 | OPNS | P | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | Loading... |
| Jan 29, 2022 | GPNX | P | NOTIFICATION PROCESSED BY IB | Loading... |
| Jan 18, 2022 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Jan 18, 2022 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Dec 29, 2021 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Dec 29, 2021 | OP2R | P | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | Loading... |
| Dec 29, 2021 | OPNS | P | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | Loading... |
| Dec 10, 2021 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Nov 11, 2021 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Nov 10, 2021 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Nov 10, 2021 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| May 16, 2021 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| May 16, 2021 | GNRT | O | NON-FINAL ACTION E-MAILED | Loading... |
| May 16, 2021 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Apr 14, 2021 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Apr 13, 2021 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Apr 13, 2021 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Dec 7, 2020 | RFNT | P | REFUSAL PROCESSED BY IB | Loading... |
| Nov 18, 2020 | RFRR | P | REFUSAL PROCESSED BY MPU | Loading... |
| Nov 18, 2020 | RFCS | P | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | Loading... |
| Oct 30, 2020 | MAFR | O | APPLICATION FILING RECEIPT MAILED | Loading... |
| Oct 28, 2020 | RFCR | E | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | Loading... |
| Oct 27, 2020 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Oct 26, 2020 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Oct 26, 2020 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Oct 22, 2020 | REPR | M | SN ASSIGNED FOR SECT 66A APPL FROM IB | Loading... |
Detailed Classifications
Class 005
Pharmaceutical and medical preparations for the treatment and prevention of infectious diseases, inflammatory diseases, kidney diseases, cancer, heart diseases, neurodegenerative diseases, deficiency diseases, autoimmune diseases, allergies; sanitary preparations for medical use; plasters for medical purposes, materials for medical and surgical dressings; disinfectants; diagnostic preparations for medical use; enzyme preparations for medical use; medicines for human use for the treatment of infectious diseases, inflammatory diseases, kidney diseases, cancer, heart diseases, neurodegenerative diseases, deficiency diseases, autoimmune diseases, allergies; pharmaceutical drugs for the treatment of inflammatory diseases, kidney diseases, cancer, heart diseases, neurodegenerative diseases, deficiency diseases, autoimmune diseases, allergies, infectious diseases; pharmaceutical preparations for the treatment of kidney diseases and disorders
First Use Anywhere:
0
First Use in Commerce:
0
Class 042
Scientific and technological services and research and design services related thereto, namely, research and design in the field of computer datacenter architecture; scientific, technological and industrial research, namely, scientific research, analysis, and reporting in the field of medicine; industrial analysis and industrial research in the field of medicine; development of technologies in the field of diagnostics, pharmaceuticals; biotechnological research related to enzymatic synthesis; testing of pharmaceuticals; quality control of goods and services; medical and pharmaceutical research services; provision of medical and scientific research information in the field of pharmaceutical products and clinical trials; drug research being pharmaceutical drug development services; research and development services for the pharmaceutical and biotechnology industry; pharmaceutical drug development; pharmaceutical product testing; development of pharmaceutical preparations and drugs; consultancy in the field of pharmaceutical research; medical research and clinical research in the field of inflammatory diseases, kidney diseases, cancer, heart diseases, neurodegenerative diseases, deficiency diseases, autoimmune diseases, allergic diseases; scientific research for medical purposes, namely, conducting clinical trials; conducting clinical trials for pharmaceutical products of others
First Use Anywhere:
0
First Use in Commerce:
0
Class 044
Services in the field of hygienic and beauty care for human beings
First Use Anywhere:
0
First Use in Commerce:
0
Additional Information
Design Mark
The mark consists of the wording "AM PHARMA" in blue, separated by a column formed by four green rectangles.
Color Claim
The color(s) blue and green is/are claimed as a feature of the mark.
Pseudo Mark
AM PHARMACY
Classification
International Classes
005
042
044
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
General Disclaimer
"PHARMA"